Article info
Case based discussion
COVID-19 vaccine-related interstitial lung disease: a case study
- Correspondence to Dr Ji Young Park, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, South Korea; evan007{at}naver.com
Citation
COVID-19 vaccine-related interstitial lung disease: a case study
Publication history
- Received May 14, 2021
- Accepted July 11, 2021
- First published August 6, 2021.
Online issue publication
December 16, 2021
Article Versions
- Previous version (6 August 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage